All episodes

Could weight loss be the key to managing heart failure? In this episode of Diabetes Insights, we dive into the STEP-HFpEF trial, a groundbreaking study exploring the role of GLP-1 receptor agonists in heart failure with preserved ejection fraction (HFpEF).
Host Vivienne Parry speaks with Prof. Melanie Davies (University of Leicester), Prof. Mark Petrie (University of Glasgow), and Prof. Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, USA) about the link between obesity, diabetes, and HFpEF, and how weight management could transform heart failure treatment.
With trials already in motion to explore prevention, could we stop HFpEF before it starts?...

In this episode of Diabetes Insights, we explore the power of screening in type 1 diabetes and the potential for early intervention. Host Vivienne Parry speaks with EASD President, Prof. Chantal Mathieu and Prof. Annette Ziegler about groundbreaking research into detecting type 1 diabetes in its earliest stages.

With new disease-modifying therapies on the horizon, early screening is no longer just about preventing complications at diagnosis but it could delay the onset of diabetes and open doors to future treatments.

We discuss how registries, European-wide collaboration, and real-world screening initiatives are shaping the future of early detection, patient monitoring, and...

In this episode, we dive into the critical role of the European Diabetes Forum (EUDF) in shaping diabetes policy across Europe. Host Vivienne Parry speaks with Bart Torbeyns about why bringing together stakeholders - including patient associations, research institutions, healthcare professionals, and industry - is essential to influencing policy makers and improving access to diabetes care.

We discuss the importance of securing diabetes on the EU agenda, tackling the rising costs of diabetes, and addressing misconceptions around obesity and new therapeutics. With European elections reshaping healthcare priorities, how can the diabetes community push for action?

Join us for a compelling...

In this episode of Diabetes Insights, we dive into the latest findings from the FLOW Trial - a groundbreaking trial evaluating the impact of GLP-1 receptor agonists on chronic kidney disease (CKD). This discussion features expert insights from Dr. Peter Rossing, Dr. Richard Pratley and Dr. Katherine Tuttle. The results reveal a 24% reduction in kidney disease progression, an 18% decrease in major cardiovascular events, and a 20% drop in total mortality - findings that could reshape clinical practice. Tune in to explore how this research is transforming diabetes and kidney disease management.

In this episode of the EASDtv Podcast, we explore a cutting-edge approach to diabetes screening - using voice. Dr Guy Fagherazzi and Dr Abir Elbeji from the Luxembourg Institute of Health discuss their research into how AI-powered voice analysis can detect subtle vocal changes linked to type 2 diabetes.

With a growing global burden of undiagnosed diabetes, this technology could provide a scalable, non-invasive screening tool accessible via smartphones. How does it work? How accurate is it? And what does this mean for the future of diabetes care?

Tune in to find out how voice-based AI could change the landscape...

In this episode, we sit down with Prof. Juleen Zierath, recipient of the 2024 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence. A former EASD President, Prof. Zierath shares insights from her pioneering research on the role of exercise in diabetes management, exploring how physical activity can improve glucose metabolism, insulin sensitivity, and overall metabolic health. She also discusses the impact of circadian rhythms on metabolism, the mysteries of insulin action, and the future of precision medicine in diabetes care.

The role of beta cells in diabetes is well established, but how important are the other cells within the islet network?
In this episode of Diabetes Insights, Prof. Mark Huising (University of California) and Prof. Guy Rutter (Imperial College London) dive into the intricate crosstalk between islet cells and its impact on insulin secretion and glucose regulation. They debate the influence of alpha and delta cells on beta cell function and explore whether these interactions could hold the key to better diabetes treatments.

In this episode, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, joins us to discuss the journals accomplishments over the past year and its vision for the future of diabetes research. From embracing AI in research processes to addressing global health disparities, Prof. Mulder highlights how Diabetologia remains at the forefront of the field.

He also shares his excitement about advancements in stem-cell and beta-cell research, the potential of precision medicine, and the role of incretin-based therapies, Prof. Mulder previews Diabetologia's special symposium on technology in diabetes care, co-created with patients, and explores how collaborative efforts are driving innovation in treatment and...

In this episode, Prof. Frank Tacke (Charité – Universitätsmedizin Berlin), Prof. Michael Roden (University of Düsseldorf), and Prof. Hannele Yki-Järvinen (University of Helsinki) discuss the groundbreaking new guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD).
The episode explores the shift from the term "NASH" to MASLD, addressing the rationale behind this change and its implications for reducing stigma and improving diagnosis. The experts delve into innovative diagnostic tools, such as FIB-4 and transient elastography, and the evolving role of GLP-1 receptor agonists and emerging liver-specific therapies.
Join us to learn how multidisciplinary collaboration between hepatologists, diabetologists, and obesity specialists is...

In this episode, we explore the vital role of National and European diabetes forums, respectively, in shaping policies and improving care for people living with diabetes. Featuring Bogdan Timor (Romanian Diabetes Forum) and Frank Nobels (Belgian Diabetes Forum), the discussion highlights how collaborative efforts, and shared strategies can drive early detection, prevention, and better management of diabetes across Europe. From Romania's groundbreaking diabetes prevention law to Belgium's integrated care and data projects, this episode showcases the power of collective advocacy in transforming diabetes care.